4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001005794-05-000706
Chief Financial Officer acquired 11,364 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CULPEPPER PETER R · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2005-08-31 | Exercise or conversion : show line 1 in the form | +11,364 | $1.10 | $12,500 | 11,364 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2005-08-31 | Exercise or conversion : show line 2 in the form Incentive Stock Option (right to buy) | −11,364 | $1.10 | 2014-02-25 | 11,364 | 288,636 | D |
Loading xslF345X02/primary_doc.xml…